SCHEMBL610339

SCHEMBL610339

NC1CN[C@H](C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8510514 1.00
SCHEMBL932832 1.00
SCHEMBL2728000 1.00
SCHEMBL610338 1.00
SCHEMBL7889338 1.00
SCHEMBL7889335 1.00
SCHEMBL8513431 1.00
SCHEMBL931937 1.00
SCHEMBL10098486 0.81
SCHEMBL10098445 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652183-A1 PEPTIDE-DRUG CONJUGATES FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) 2025-11-26 EP claimed
US-20250109171-A1 COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) 2025-04-03 US claimed
CN-117903241-B Polypeptide probe for detecting tumor lesion collagen and preparation method and application thereof 甘肃天际生物科技有限公司 2024-12-24 CN claimed
EP-4464715-A2 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 BicycleTx Limited (GB) 2024-11-20 EP claimed
CN-118984715-A Compositions for the treatment of macular degeneration comprising novel peptides 韩国视角生物株式会社 2024-11-19 CN claimed
US-20240376155-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL CANCERS Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) 2024-11-14 US claimed
EP-4450079-A1 COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE EyebioKorea, Inc. (KR) 2024-10-23 EP claimed
EP-4196608-B1 NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSITIVELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME HOFFMANN LA ROCHE (CH) 2024-10-23 EP claimed
CN-118406404-A Circuit board ink-jet printing ink stripping agent and preparation method and application thereof 珠海市板明科技有限公司 2024-07-30 CN claimed
WO-2024153162-A1 PEPTIDE-DRUG CONJUGATES FOR TARGETED THERAPY OF RENAL DISEASES SHANGHAI MICURX PHARMACEUTICAL CO., LTD. (CN) 2024-07-25 WO claimed
CN-1142228-A Novel amino acid derivatives, method of producing same and pharmaceutical compositions containing these compounds BOEHRINGER INGELHEIM KG (DE) 1997-02-05 CN claimed
US-5596000-A NEUROKININ ANTAGONISTS BOEHRINGER INGELHEIM KG (DE) 1997-01-21 US claimed
WO-1995030687-A1 NEUROKININE (TACHYKININE) ANTAGONISTS BOEHRINGER INGELHEIM KG (DE) 1995-11-16 WO claimed
WO-1995023810-A1 NOVEL AMINO ACID DERIVATIVES, METHOD OF PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1995-09-08 WO claimed
EP-0394989-B1 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-21 EP claimed
EP-0610487-A1 NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1994-08-17 EP claimed
CN-1086222-A Amino acid derivatives, process for their preparation and pharmaceutical compositions containing them BOEHRINGER INGELHEIM KG (DE) 1994-05-04 CN claimed
WO-1994005693-A1 NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM KG (DE) 1994-03-17 WO claimed
US-5164372-A Treatment of respiratory disorders, inflammation, dermatitis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-11-17 US claimed
EP-0394989-A2 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-31 EP claimed